On the contrary, KRAS (Kirsten rat sarcoma viral oncogene homolog) mutations are observed in ~15% of NSCLC Asians patients and ~30% of NSCLC Caucasians patients. This evidence concerns the gene KRAS and non-small cell lung carcinoma.